Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Hereditary forms of apparent mineralocorticoid excess (AME): Report of a further case and literature review

Breadcrumb

  • Home
  • Hereditary forms of apparent mineralocorticoid excess (AME): Report of a further case and literature review

Amirah D. Albalawi 1, Sharifah D.A Al-Issa 1, Mohammed Ahmed AlHissi 1, Abdulrahman N A Aljurayyan 2, Jumana J Khoder 3 and Nasir A M Al-Jurayyan 1, *

1 Department of Pediatrics, College of Medicine and King Khalid University Hospital (KKUH), King Saud University, Riyadh, Saudi Arabia.
2 King Khalid University Hospital (KKUH), King Saud University, Riyadh, Saudi Arabia.
3 College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2023, 15(01), 180–184.
Article DOI: 10.30574/wjbphs.2023.15.1.0284
DOI url: https://doi.org/10.30574/wjbphs.2023.15.1.0284

Received on 17 May 2023; revised on 23 June 2023; accepted on 26 June 2023

The syndrme of apparent mineralocorticoid excess (AME) is an extremly. rare autosomal recessive disorder. To date, more than 100 reported cases in the medical literature world-wide. It is caused by an impairment in the enzym 11-b-hydroxy steroid dehydrogenase (11-b-HSD) enzyme type 2, characterized by early onset hypertension, hypokalemia, metabolic alkalosis, low levels of seum renin and aldosterone. The majority of patients are usually have a low birth weight and failure to thrive (FTT). Nephrocalcinosis could be present. We describe an 11.5 year old girl, who presented in early infancy with poor growth, and not until a gene study done recently, which revealed a homozygous pathogenic variant in the HSD 11B2 gene c. 622 C >Tp. (Arg208 Cys ). This is consistent with the diagnosis of AME This emphasizes the importance of genetic testing in the diagnosis of AME. A high index of suspicion required in managing such patients. Increased awarness among health care professionals is needed to avoid potential health hazards.

Apparent Mineralocorticoid Excess (AME); 11-b-Hydroxy Steroid Dehydrogenase Enzyme 2; (11-b- HSD2); Hypokalemia; Alkalosis; Renin; Aldosterone; Failure to thrive (FTT); Genetic study

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2023-0284.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Amirah D. Albalawi, Sharifah D.A Al-Issa, Mohammed Ahmed AlHissi , Abdulrahman N A Aljurayyan, Jumana J Khoder and Nasir A M Al-Jurayyan. Hereditary forms of apparent mineralocorticoid excess (AME): Report of a further case and literature review. World Journal of Biology Pharmacy and Health Sciences, 2023, 15(01), 180–184. Article DOI: https://doi.org/10.30574/wjbphs.2023.15.1.0284

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution